How gut bacteria can be an ally in cancer treatment: An emerging paradigm
In a new forum article in the journal Cell Metabolism, Rachel Newsome, Ph.D., and Christian Jobin, Ph.D., highlighted a paradigm shift in the field.
In a new forum article in the journal Cell Metabolism, Rachel Newsome, Ph.D., and Christian Jobin, Ph.D., highlighted a paradigm shift in the field.
Rachel Newsome will present her research on harnessing the gut microbiome to enhance the effectiveness of cancer immunotherapy treatment.
The award funds her research that harnesses gut microbiota in cancer immunotherapy response.
The promising strategy could be used in combination with other treatments to increase the effectiveness of glioblastoma therapies.
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.
The project builds on the team’s recent development of a PROTAC that showed potential as a small-molecule-based therapy.